webinar register page

Biomarker Testing: Improving Access to Improve Care (IL)
Cancer has proven to be a major burden for the Hispanic community, which accounts for nearly 20% of America's population. In fact, the leading cause of death for Hispanic Americans is cancer; one in three Hispanics will be diagnosed with cancer in their lifetime. Despite being at a higher risk for certain cancer types, Hispanic Americans, as compared to their non-Hispanic White counterparts, are underdiagnosed for the most common cancers. Knowing this information, NHMA and Amgen Inc. have partnered to develop a webinar series to educate the public on the impact of cancer on Hispanic Americans and disparities in cancer care and outcomes. In this webinar, we will be joined by Dr. Florez who is a board certified in internal medicine. Her interests includes targeted therapy for lung cancer and care for women who are diagnosed with lung cancer. She will be sharing a real patients story and much more!

Moderator: Dr. Elena Rios
President & CEO
National Hispanic Medical Association

Narjust Florez, MD
Associate Director, Cancer Equity Program
Thoracic Medical Oncologist, Dana-Farber Cancer Institute/Harvard Cancer Center
Faculty Member, Harvard Medical School

Jul 21, 2022 12:00 PM in Eastern Time (US and Canada)

NHMA logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: NHMA.